key: cord-0978693-mba9z3fo authors: Gholivand, Khodayar; Barzegari, Azam; Mohammadpanah, Fahimeh; Yaghoubi, Rouhollah; Roohzadeh, Roohollah; Asghar Ebrahimi Valmoozi, Ali title: Synthesis, characterized, QSAR studies and molecular docking of some phosphonates as COVID-19 inhibitors date: 2022-04-04 journal: Polyhedron DOI: 10.1016/j.poly.2022.115824 sha: e97aab024c89998dd8047a9141232df27f41e07a doc_id: 978693 cord_uid: mba9z3fo The global coronavirus (COVID-19) outbreak has prompted scientists to discover a cure for the disease. So far, phosphorus-based drugs have been proposed. These drugs have good inhibitory activity against the main protease (Mpro). Hence, in order to introduce a group of inhibitors the coronavirus, 51 compounds containing different mono, bis, and tetra phosphonates as Remdesivir derivatives, 32 of which are new, were synthesized and characterized by (31)P, (13)C, and (1)H NMR and IR spectroscopy. Their biological activities were also investigated by Molecular Docking, QSAR, and Pharmacophore. Van der Waals, hydrogen bonding, and hydrophobic interactions were studied for all compounds as well as binding energy (△G, Kcal/mole) and the inhibitory constant Ki (μM) obtained by Molecular Docking. The results showed that the topology of the ligands and the change of the different groups attached to them can be effective in the placement position in the active site of the enzyme (Glu 166 and Gln 189). And bisphosphonates have a high interaction tendency with Mpro COVID-19. Compound L24 was identified as the best inhibitor with the -6.38 kcal/mol binding energy. The quantitative structure-activity relationship (QSAR) findings demonstrated that the polarity and topology of molecules in all phosphonate derivatives were important parameters affecting the effecting on the binding energy and inhibitory ability of compounds. The DFT and pharmacophore results are in good accordance with those of QSAR and molecular docking. This study can be helpful to gain a better understanding of the interactions between the Mpro of virus and its inhibitors in order to attain drugs with more effect on coronavirus (COVID-19). Research based on chemistry and biology greatly contributes to the production of bio-inhibitors. According to the electronic and structural properties of phosphonates such as the phosphoruscarbon stable covalent bond and their high potential in biology, Phosphonate chemistry can be introduced as a suitable candidate for the production of biomaterials [1] [2] [3] . Phosphonates have a wide range of application in radiopharmaceuticals [4] , enzyme inactivators [5] , HIV protease inhibitor [6] , cardiovascular drugs [7] , anti-parasitic drugs [8] , and antiviral drug [9] . On 11th March 2020, the World Health Organization (WHO) categorized COVID-19, as a pandemic disease [10, 11] . To date, there is no definitive treatment for COVID-19; however, scientists are working hard to prevent and find its safe treatment albeit, some useful drugs were introduced by them [12] . One group of these proposed treatments was antiviral drugs based on phosphorus amide and phosphonates such as tenofovir, Adefovir, Sofosbuvir, Foscarnet, Uprifosbuvir, and Remdesivir, but any country didn't approve them as a reliable treatment for coronavirus [12] [13] [14] [15] . Thus, produced intensifying drugs based on phosphorus compounds, HIV and malaria drugs were tested for COVID-19 [16, 17] . Quantitative Structure-Activity relationship (QSAR) is a tool to discover the relationship between the structure and activity of chemical compounds. In the face of unknown disease particularly COVID-19, this technique and molecular docking have brought benefits to design and produce new drugs [18] [19] [20] [21] . In this research, due to the extensive biological properties of phosphonates as well as their ability to inhibit the main protease, 51 phosphonate derivatives including mono, bis, and tetra (Scheme 1-3) have been used to study interactions with COVID-19 (PDB ID 6LU7) (http://doi.org/10.2210/pdb6LU7/pdb). The parameters affecting the inhibitory activity of the The compounds used to synthesize the ligands were commercial products of Merck. 1 H, 13 C and 31 P NMR spectra were recorded at room temperature on a Bruker Avance DRS 500 MHz spectrometer. The chemical shifts of 1 H, 13 C and 31 P were obtained in D 2 O solvent, with reference TMS as an internal standard. The IR spectra of the synthesized ligands were recorded on a Shimadzu IR-60 model spectrometer using KBr pellets in the range 400-4000 cm −1 . All of the ligands were synthesized based on a Mannich reaction [25] . 1mmol of Secondary (2°) amine was blended in 5mL 37% hydrochloric acid, 5mL deionised water, and 1.5 mmol phosphorous acid. This mixture was refluxed at100-120°C for 1.5 h, then 2 mmol of paraformaldehyde was added dropwise it over a period of 1h and the solution was refluxed again for one hour. The solution was dried at room temperature, and after washing with ethanol, was obtained a pure product. The Ligands L8 and L9 have been synthesized in the previous work [26] , but other ligands synthesized and were characterized with 1 H, 13 C, 31 31 The method mentioned above is also used to synthesize this group of compounds. 1mmol amount of Primary (1°) amine was mixed with 5mL 37% hydrochloric acid, 5mL deionised water, 3 mmol phosphorous acid and refluxed at100-120°C for 1.5 h. In the last step, 4 mmol of paraformaldehyde was added to the mixture like the previous method. Finally, a powder was obtained that was characterized with 1 H, 13 C, 31 P NMR, and IR spectroscopy (see supplementary information). Ligands L13, L19, L22, L23, L27, L28, L29, L30, L31, L32, L34, L35, L36, L40, and L42 have been synthesized in the previous works [26, 27] . 31 1 H NMR (D 2 O, ppm): δ = 1.39 (s, 6H, 2CH 3 ), 1.41 (s, 6H, 2CH 3 ), 1.86(t, 2H, 2CH 2 (α)), 2.32(d, 2H, 2CH 2 (β)), 3.51 (d, Ligands L43 to L51 were synthesized by Mannich reaction. This synthesis method is exactly the same as the previous two batches, but 1millimol of diamine and 6mmol phosphorous acid was used, here. The results were characterized with 1 H, 13 C, 31 P NMR, and IR spectroscopy (see supplementary information). The data of L43, L49, and L50 is brought in another paper [26] . The X-ray crystallographic structures of COVID-19 main protease (PDB ID 6LU7) are available on the Protein Data Bank (PDB (http: //www.pdb.org.) database, and this was saved by the PDB format. The file of receptor protein contains A and B chains that chain A was used for the preparation receptor protein. Water molecules and Crystallized ligand in crystal structures of 6LU7 were removed using BIOVIA Discovery Studio 2019 (DS) [28] . To create pdbqt file, polar hydrogen atoms and Kollman united atom charges were added to the receptor protein by Auto Dock Tools-1.5.6 (ADT) program [29, 30] . The molecular structures of the ligands (L1-L51) were drawn in GaussView 6.0.16 software and optimized in the Gaussian 09W using basis set b3lyp/6-311+g (d,p) [31] and the log file of each ligand saved with pdb format in GaussView. For all ligands, Gasteiger charge was assigned, and non-polar hydrogens were merged by Auto Dock Tools (ADT); then pdbqt files of the ligands were generated for docking simulation. In order to study the inhibition of COVID-19 by phosphonates, a series of mono, bis, and tetra phosphonates were selected to investigate their binding affinity in the SARS-CoV-2 Mpro active site (S4). These compounds were previously synthesized by our group [26, 27] . In this study, binding energies (△G) values of the compounds from Docking in Table 1 were used as dependent variables. It is essential to build numerical descriptors of a set of inhibitors in order to build QSAR models. Descriptors can represent quantitative properties that depend on the structure of the molecules. Advantage of use of theoretical descriptors is that they are free of the uncertainty of experimental measurements and can be calculated for compounds not synthesized [33] . Molecular descriptors were computed using the DRAGON software for a set of 51 phosphonates as coronavirus inhibitors [34] . A total of 1478 molecular descriptors of different kinds (0, 1, 2, and 3D) were used to describe the chemical diversity of the compounds. The descriptor typology is: a) constitutional Table S 1 ) . Therefore, the set of descriptors contains D = 1496 features [35, 36] . The correlation between biological activity and structural properties was obtained using the variable selection Genetic Algorithm-A stepwise multiple linear regression (GA-SW-MLR) methods. We applied the Genetic Algorithm to select from all the calculated descriptors only the best combinations of those and the most relevant for obtaining models with the highest predictive power for the binding energy of compounds with COVID-19 Mpro. Genetic Algorithms have been employed in recent years as a powerful tool to optimize many problems in drug design [33, 37, 38] . This approach allows the selection of the models with the following characteristics: high correlation coefficient R, low standard deviation S, and the least number of descriptors involved [39] . In order to evaluate the generated models, leave-one-out cross-validation is used. In this algorithm, one compound is left in each step as a prediction set, and the model is developed using the remaining molecules as the training set [40] . For further exhaustive testing of the prediction power of the model, in addition to LOO-CV, the leave-multiple-out cross-validation (LMO-CV) algorithm was also carried out. Then the ΔG of this group was predicted by the model developed by using the remaining observations as the training set [40] . Computer techniques such as molecular docking have been very effective in drug designing against new diseases. This method provides better insight into the binding of ligands to protein, bond lengths, binding energies, and types of interactions. Furthermore, the molecular docking considers the effect of various factors on the ligand ranging from ring size to aliphatic chain length to the presence of different atoms, and to electronegative and electropositive groups when interacting with the protein. In this work, the interactions between the different phosphonate compounds and the X-ray crystal structure of COVID-19 (PDB ID: 6LU7) were studied by molecular docking. The aim of this study is to investigate the inhibitory potency of a group of phosphonate derivatives against the coronavirus and to evaluate the most effective electronic and structural factors in this process. Three series of compounds were classified as mono, bis, and tetra phosphonates, respectively. The binding energies were measured for the mono and bisphosphonates in the range of -3.26 to -6.38 kcal/mol, Well-known antiviral drugs (Table 4) were compared to the synthesized compounds, in terms of Docking parameters, Remdesivir (-6.75 kcal/mol), Adefovir (-4.18 kcal/mol), Tenofovir (-4.97 kcal/mol), and Foscarnet (-3.13 kcal/mol). Therefore, it can be anticipated that mono and bisphosphonates could be effective against COVID-19 as possible medicinal agents. Results of docking studies of monophosphonates and 6LU7 are reported in Table 1 Figure 1A . Also, hydrogen bonds were observed between the C=O functional group of Glu 166 and O-H groups of L12 at a distance of 2.77 and 2.88 A°. The hydrophobic interactions were shown between residues and different sections of the ligand L12 with red color (Fig. 1B) . The π-Sulfur and π-alkyl interactions were observed between the phenyl ring of L12 with the sulfur atom of Met 165 and the alkyl group of Pro 168 at a distance 5.40 A° and 5.47 A°, respectively (Fig. 1C ). (Table. 2). The plausible binding mode of L24 and the active site of 6LU7 is displayed in Fig. 2A . As can be seen, acidic hydrogens were involved in the formation of hydrogen bonds with Asn142, Phe140, Gln192, Arg188, and Thr190 residues from the active site of the Mpro, respectively. The hydrophobic interactions were shown in red color between residues and different sections of the compound L12 (Fig. 2B) . Furthermore, the phenyl ring was connected to Met165 via π-Alkyl bonds with distance 5.34 A°. These interactions have led to more stability of the target complex (Fig. 2C ) the best interactions with protein 6LU7 in tetraphosphonates (Fig. 3A) . The hydrophobic residues interactions of 6LU7 with L44 were shown by the red dashed line (Fig. 3B, 3C) . Several hydrogen bonds are seen between the hydrogen of O-H group in L44 with the oxygen of C=O group in Asn142, Glu166, the nitrogen of N-H in Glu166, and Asn142 (Fig. 3B) . Also, π-sulfur and πcation stacking interactions have been respectively observed between the phenyl ring of L44 with the sulfur atom of Cys 145 and the NH 3 + of residue His 163 at a distance 4.69 A° and 5.57 A° (Fig. 3C) . constant (Ki) showed that the bisphosphonates had a higher inhibitory effect and lower binding energy than those of other derivatives ( Figure 4A ), And L24 can be considered as the most active compound. The increasing number of phosphonate functional groups could not be considered as an effective factor for inhibition and interactions in active sites of the protein ( Figure 4B) . Also, the connection desire of the phosphonates to Mpro depends on the type of their topology, inhibitors' substituents, and their ability to form interactions with active sites of the protease. (kcal/mol) ( Table 4 ). The binding energy of mono, bis, and tetraphosphonates are in the mentioned range (except linear tetraphosphonates). Moreover, the amino acid residues involved in hydrogen bonding for these drugs are similar to the amino acid residues for L12, L24, and L44 that the maximum of repetition and similarity is observed for residues Glu 166 and Gln 189. Binding map for L49-L51 is provided in S1-S3. it can be said that ∆G values are related to the type of amino acid that reacts with the ligands. So the mentioned drugs, in Table 4 , can be used as a reference to confirm the inhibition of 6 LU7 by synthesized compounds. According to this research and to obtain a logical relationship between the structure and activity of compounds, the QSAR study was performed. Table 5 . The consistency and reliability of these models were validated using the leave-one-out (LOO) and leave-multi-out (LMO) cross-validation techniques. The consistency of the Q2 values for LOO and LMO data sets indicated that the proposed models were reliable. The observed GA-SW-MLR predicted values of the △G for all COVID-19 inhibitors studied in this work are shown in S2-S5. In the final step, to interpret the inhibition mechanism, the most significant predictors appearing in the GA-SW-MLR models were examined. In GA-SW-MLR models, the mean effect of each descriptor could be considered as the relative mean effects [41] . Figure 5 shows the importance of each variable for the QSAR models. The appearance of χ and S, and Gap molecular descriptors in the QSAR model 1 shows the critical role of the electronegativity, chemical hardness, and gap energy of the molecules in mono phosphonates inhibition behavior against the main protease of COVID-19. The selection of these descriptors in this model implies that the inhibition mechanism was an electrical-based procedure. The behavior of bisphosphonates in the QSAR model 2 shows that structural descriptors (nB0, SNar, nHAcc) are more momentous than electronic descriptors (X). The nB0 and SNar were two of the effective factors of this model, which displays the importance of number non-hydrogen bonds (π−π stacking, hydrophobic interactions) and molecule topology in the inhibition mechanism. Indeed, SNar is a Narumi simple topological index related to molecular branching proposed [42] . These descriptor coefficients are negative, meaning that increasing non-hydrogen bonds and the molecular branching can lead to the reduction of the value of the binding energy of compounds with COVID-19 Mpro and better interact with the connection sites. 9are negative correlated with the binding energy of tetra phosphonates with COVID-19 Mpro. The nCIR is a structural descriptor, which is related to molecular flexibility. Indeed it includes both rings and circuits (a circuit is a larger loop around two or more rings). And inhibitory ability increases with the increase in average molecular weight, the number of rings, and circuits. In the QSAR study of model 4 with all phosphonate derivatives mentioned in this work, it was shown that structural (SNar, nHAcc) and electronic parameters (χ Ss, μ, D) affect the biological behavior of these derivatives. Descriptor χ was one of the parameters, affecting the inhibitory behavior of mono and bis and all phosphonates against COVID-19 Mpro. The electronic chemical potential [χ = (EHOMO+ELUMO)/2] is the escaping tendency of electrons from a species in its ground state and is the negative of absolute electronegativity [41] . The compound has greater interaction with the active site of COVID-19 Mpro when greater χ, the less bonding energy. The Ss is calculated by dividing the sum of Kier−Hall electro-topological states by the number of non-hydrogen atoms [43] . This predictor is related to the electronic essence of the molecules, namely the number of valence electrons and the principal quantum number of atoms in molecules [39] . With increasing Ss, the polarity of these compounds increases, and the electronic interactions between the inhibitors and the active site COVID-19 Mpro increase. The nHAcc is the number of hydrogen bond acceptors (number of OH and NH atoms). Examination of this factor showed that as the number of OH and NH atoms in the structure increased, the bonding energy decreased, and the inhibitory power increased. The μ and  descriptors are the dipole moment and density of molecules. Figure 5 and Table 5 show that the dipole moment and density are correlated with the binding energy. Indeed, the binding energy decreases with their increase. Comparing the QSAR models showed that the difference between descriptors and Inhibition mechanism in models QSAR could explain the reasons for the diverse behavior of inhibitors in these three groups phosphonate. The electronic descriptor in the QSAR model mono phosphonate, structural descriptors in the QSAR model tetra phosphonate, and both structural and electron parameters in the QSAR model bisphosphonate were effective on binding energy. Molecule topology, chemical potential, and the number of hydrogen bond acceptors were common descriptors between QSAR models 1, 2, and 4. The analysis of Frontier molecular orbitals of ligands is one of the methods used to predict reactive electrophilic or nucleophilic sites [44] . The lowest unoccupied molecular orbital (LUMO) and highest occupied molecular orbital (HOMO) are called frontier molecular orbitals. HOMO-LUMO energies were calculated using DFT at B3LYP method and 6-311+G** basis set for all the ligands. Our study revealed that, in general, the bisphosphonates had a stronger inhibitory activity compared to monophosphonates. HOMO-LUMO plots of the L12 and L24 are gathered in Figure 7 . HOMO-LUMO gap energies of ligands L12 and L24 calculated 4.68 eV and 5.44 eV respectively; these values are comparable with the bandgap energy values of the bioactive molecules. The desirability of these values for these compounds indicates its tendency to interact with the COVID-19 acceptor as a bioactive molecule. In the case of compound L12, the HOMO plot was scattered on oxygens (phosphonate), nitrogen amine, and methyl phenyl benzenamine moieties, and LUMO was composed of the benzen rings. The ligand L24, HOMO was scattered over the nitrogen atom (1), oxygen atoms (1, 2, 3), and LUMO was spread overall structure. Frontier orbital energies can affect the inhibitory activity through charge transfer and π−π stacking between inhibitors and amino acid residues in the binding site of COVID-19 Mpro. The results of the study of molecular docking on phosphonate derivatives showed that these regions of this compound participated in important interactions with the main residues of the COVID-19 Mpro To determine the pharmacophore features which are significant for the use in drug discovery, we carried out ligand-based pharmacophore modeling. For this purpose, the strongest inhibitors (L12, L24) and reference molecules were subjected. Pharmacophore features such as aromatic ring and hydrophobic group, hydrogen-bond acceptor, hydrogen-bond donor, positive and negative ion, etc., may be useful for understanding the specific activity of molecules. The common pharmacophores from the reference molecule (Tenofovir) showed nine hydrogen bond acceptors (Yellow), five hydrophobic groups (Green), and two aromatic rings (Purple) ( Figure 8A ). The second reference molecule (Adefovir) showed seven hydrogen bond acceptors, two hydrophobic groups, and two aromatic rings ( Figure 8B) , and L12 showed three hydrogen-bond acceptors, two hydrophobic groups, two aromatic rings, and one negative ion (Red) (Figure 8C ), as well as L24, displayed eight hydrogen bond acceptor, one hydrophobic group, and two negative ions ( Figure 8d ). Hydrogen bond acceptors, hydrophobic groups, and negative ions were common pharmacophores in all structures of phosphonates that are helpful for binding with receptors. These results were in good agreement with those of QSAR and molecular docking. The biggest crisis in recent years has been the appearance of COVID-19 disease and public health challenges. So far, many antiviral agents have been tested, but they have not been completely effective due to the side effects on other organs. Therefore, there is an attempt to find new ways to improve or control the prevalence of this disease. Phosphonate derivatives have been used here. By changing different functional groups in each category, the amount of binding energy is determined using molecular docking. The topology of the ligands and the change of the different groups attached to them can be effective in the placement position in the active site of the enzyme (Glu 166 and Gln 189).Compound L24 was identified as the best inhibitor with the -6.38 kcal/mol binding energy. In general, bisphosphonate had a higher inhibitory effect and lower binding energy than other phosphonates. QSAR calculation results using the Genetic Algorithm -Stepwise multiple linear regression (GA-SW-MLR) method for mono, bis, tetra phosphonate reveal that the difference between descriptors and Inhibition mechanism in QSAR models can explain the reasons for the diverse behavior of inhibitors. The electronic descriptor in the QSAR model of the mono phosphonate, structural descriptors in the QSAR model of the tetra phosphonate, and both structural and electron parameters in the QSAR model of bisphosphonate were effective on binding energy. Molecule topology, chemical potential, and the number of hydrogen bond acceptors were common descriptors between QSAR models mono, bis, and all phosphonate derivatives. The DFT and pharmacophore were used to verify docking and QSAR. Corresponding Author ‫٭‬Phone: +98 21 82883443; fax: +98 218006544; e-mail gholi_kh@modares.ac.ir An Aminopyrrolidinyl Phosphonates-A New Class of Antibiotics: Facile Synthesis and Predicted Biological Activity The Hydrolysis of Phosphinates and Phosphonates: A Review Recent Advances in Synthesis of Difluoromethylene Phosphonates for Biological Applications. Advanced Synthesis & Catalysis Synthetic phosphonic acids as potent tools to study phosphonate enzymology Synthesis of phosphonate derivatives of 2'-deoxy-2'-fluorotetradialdose d-nucleosides and tetradialdose d-nucleosides Medicine in Drug Discovery 2020 Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet. Bioorganic & medicinal chemistry letters Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach Treatment for COVID-19: An overview The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID: 6LU7) Using Molecular Docking silico studies on therapeutic agents for COVID-19: Drug repurposing approach Synthesis, characterization and computational study on potential inhibitory action of novel azo imidazole derivatives against COVID-19 main protease (Mpro: 6LU7) Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach SARS CoV Mpro inhibitory activity of aromatic disulfide compounds: QSAR model Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein-Human ACE2 Receptor Interface Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19 QSAR model for drug human oral bioavailability Software for molecular docking: a review MolDock: a new technique for high-accuracy molecular docking Nitro-mannich reaction Synthesis, crystal structure, cholinesterase inhibitory activity, evaluation of insecticidal activities, and computational studies of new phosphonic acids Design, synthesis and anticholinesterase activity of some new α-aminobisphosphonates Molecular docking and structurebased drug design strategies Molecular docking: a powerful approach for structurebased drug discovery Systematic errors in computed alkane energies using B3LYP and other popular DFT functionals LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery A Quantitative Structure-Activity Relationship (QSAR) Study of the Antioxidant Activity of Flavonoids DRAGON software for the Calculation of Molecular Descriptors, web version 3.0 for Windows Quantitative structure-activity/ecotoxicity relationships (QSAR/QEcoSAR) of a series of phosphonates DFT study on structure, electronic properties, and reactivity of cis-isomers of Handbook of Genetic Algorithms Genetic Algorithms in Molecular Modeling Modeling GC-ECD retention times of pentafluorobenzyl derivatives of phenol by using artificial neural networks QSAR Modeling of 1-(3, 3-Diphenylpropyl)-Piperidinyl Amides as CCR5 Modulators Using Multivariate Adaptive Regression Spline and Bayesian Regularized Genetic Neural Networks Synthesis, crystal structure, insecticidal activities, molecular docking and QSAR studies of some new phospho guanidines and phospho pyrazines as cholinesterase inhibitors Molecular descriptors for chemoinformatics: volume I: alphabetical listing/volume II: appendices, references Modeling the cellular uptake of magnetofluorescent nanoparticles in pancreatic cancer cells: a quantitative structure activity relationship study Evaluating anti-coronavirus activity of some phosphoramides and their influencing inhibitory factors using molecular docking, DFT, QSAR, and NCI-RDG studies This paper consists of new mono, bis, and tetraphosphonate compounds that were selected against COVID-19 M pro . Computational studies based on molecular docking, the quantitative structureactivity relationship (QSAR), and the pharmacophore studies were conducted to detailed study the inhibitory potency of compounds against COVID-19 M pro and the factors influencing inhibitory potency The financial support of Tarbiat Modares University's Research Council is gratefully acknowledged. Calculations relative to experiment and spectral data (ligand L1-L7, L10-L12, L14-L18, L20, L21, L24-L26, L33, L37, L38, L41, L44 -L49) and computational details.